Serum HMGB1 and Alcohol-Related Liver Disease

Iwona Popiolek1,2, Piotr Hydzik1,2, Krzysztof Ciszowski1,2

  • 1Department of Toxicology and Environmental Diseases, Jagiellonian University Medical College, Botaniczna 3, 31-503 Kraków, Poland.

Insights

Circulating High-mobility group box 1 (HMGB1) is detectable in some patients with alcohol-related liver disease (ALD) and indicates greater disease severity. This potential biomarker is more frequent in ALD patients than controls.

Area of Science:

  • Hepatology
  • Biomarker Discovery
  • Immunology

Background:

  • Alcohol-related liver disease (ALD) lacks validated biomarkers for disease activity and severity.
  • High-mobility group box 1 (HMGB1), a damage-associated molecular pattern, is implicated in ALD pathogenesis.

Purpose of the Study:

  • To evaluate the detectability of circulating HMGB1 in patients with ALD during active alcohol consumption.
  • To examine the clinical associations of detectable HMGB1 in ALD patients.

Main Methods:

  • Observational study of hospitalized adults with ongoing ethanol use and healthy controls.
  • Serum HMGB1 measured by ELISA; clinical features and severity scores (MELD, MELD-Na, CLIF-C AD) recorded.

Main Results:

  • HMGB1 was detectable in 47% of ALD patients vs. 11% of controls.
  • Detectable HMGB1 correlated with higher bilirubin, creatinine, white cell count, and greater MELD, MELD-Na, and CLIF-C AD scores.
  • No significant differences in mortality or readmission rates based on HMGB1 status.

Conclusions:

  • Detectable circulating HMGB1 is present in a subset of ALD patients.
  • HMGB1 detectability is associated with increased liver disease severity in ALD.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...